logo negro baker tilly
Contacto

kala

kala

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 238 [name] => biotecnología [slug] => biotecnologia [term_group] => 0 [term_taxonomy_id] => 238 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 23 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 209 [name] => inversión [slug] => inversion [term_group] => 0 [term_taxonomy_id] => 209 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 25 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 572 [name] => kala [slug] => kala [term_group] => 0 [term_taxonomy_id] => 572 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 573 [name] => ysios [slug] => ysios [term_group] => 0 [term_taxonomy_id] => 573 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) )
Ysios capital participa en una ronda de $68 M en Kala pharmaceuticals
Ysios capital, gestora de capital riesgo líder en el sector de la biotecnológico en España anunció el pasado 14 de A [...]
seguir leyendo >>
crossmenuchevron-down